Observational Study of NanoBone® Bone Graft in Acute Trauma
This study is an observational registry looking at how orthopedic surgeons use NanoBone® Bone Graft in patients with acute fractures (broken bones) in their arms, legs, or pelvis that need surgery. It aims to understand how well NanoBone® works by tracking fracture healing using X-rays and how patients' symptoms and function improve. You might be eligible if you are at least 18 years old and have an acute fracture requiring surgery where bone grafting is needed. The study will follow your progress to see if the fracture heals and how you recover. The goal is to document how this device is used and its outcomes in real-world settings.
- Study design
- This is an observational study, meaning researchers will collect information about how NanoBone® Bone Graft is used in about 200 patients. It is not a randomized trial where treatments are assigned.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your fracture healing will be checked with X-rays at 2 weeks, 6 weeks, 3 months, and 6 months after surgery.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Prospective Registry to Evaluate Outcomes of NanoBone® Bone Graft in Acute Trauma
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Mitchell D Kuhl, DO · PRINCIPAL_INVESTIGATOR · SSM Health
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Radiographic evidence of fracture healing2 weeks, 6 weeks, 3 months, 6 months
AP and lateral x-rays